With the rising incidence of cancer in India, AstraZeneca India's breast cancer medicine trastuzumab deruxtecan (sold under ...

The Indian rupee has depreciated 3.3 per cent against the US dollar between October 2024 and January 2025, but the decline has been lower than some of its Asian currencies, Minister of State for ...

The scheme aims to deliver affordable generic drugs, which can be 50-80% cheaper than branded varieties, but has been hobbled ...

The Indian rupee has depreciated 3.3 percent against the US dollar between October 2024 and January 2025, but the decline has been lower than some of ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

The outgoing Hamilton County Republican Party chairman says the conservative grassroots Activate Hamilton slate is using ...

Deep Research is an AGI product for certain narrow domains; it’s ability to find anything on the Internet will make secret knowledge all the more valuable.

Here's how popular rom-coms and romantic dramas like "The Half of It," "The Kissing Booth 2," and "To All the Boys I've Loved ...

Arrowhead Pharmaceuticals, Inc. ( NASDAQ: ARWR) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Chris Anzalone - President & CEO Bruce Given - Interim Chief Medical Scientist Andy Davis ...

Probably over the next few months, he will stabilise and put some tariffs which are very selective, but there will be a give ...

The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported results. Among these, Bristol Myers reported better-than-expected ...

Axsome settles Auvelity patent litigation with Teva, delaying a generic launch until 2038. Analysts see growth potential with Symbravo's migraine approval.